Comparison of body mass index on children with functional constipation and healthy controls

Zohreh Kavehmanesh1, Amin Saburi2, Ali Maavaiyan3

  • 1Department of Pediatric, Faculty of Medicine and Research Center of Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Insights

Obesity shows a significant link to the duration of pediatric constipation, but not its presence. Further research is needed to confirm the impact of weight changes on defecation in children.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Public Health

Background:

  • Constipation is a common pediatric disorder, categorized as organic or functional.
  • Obesity is a growing pediatric concern impacting growth and development.
  • This study investigates the potential link between childhood obesity and functional constipation.

Purpose of the Study:

  • To evaluate the probable relationship between obesity and pediatric functional constipation.
  • To analyze the association between Body Mass Index (BMI) and constipation in children.
  • To explore factors influencing constipation in obese and non-obese pediatric populations.

Main Methods:

  • A case-control study involving 259 children aged 2-14 years.
  • Exclusion of children with organic causes of constipation.
  • Comparison of Body Mass Index (BMI) between constipated children and a healthy control group.

Main Results:

  • No statistically significant difference in the prevalence of obesity between constipated and control groups (P = 0.188).
  • A significant association was found between obesity and the duration of constipation (P = 0.008).
  • Obesity also showed a significant association with the age of the children (P = 0.042).

Conclusions:

  • While obesity is linked to constipation duration, a clear association with constipation presence was not established.
  • Further cohort or clinical trials are recommended to explore regional nutritional and growth patterns.
  • Investigating the effect of weight changes on defecation requires additional research.
Abstract

Related Concept Videos

Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
2.1K
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
663
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
36